Large international study finds 40% higher risk of serious cardiovascular problems in people taking abacavir since 2012
New cases of multi-drug resistant HIV becoming rarer in Europe
Large US study confirms that people switching from TDF to TAF experience rising blood fat levels
Working together to improve HIV care in Europe
People with HIV taking newer antiretrovirals at higher risk of fatty liver disease
Older version of tenofovir used as PrEP linked to weight loss
Most switches to Descovy PrEP are probably unnecessary and some may be harmful
Two thirds of HIV controllers in French cohort haven’t needed HIV treatment yet
People over 50 years old or with existing kidney dysfunction are more likely to get kidney damage when using tenofovir disoproxil-based PrEP
